FKBP51 Affects Cancer Cell Response to Chemotherapy by Negatively Regulating Akt

Cited by (727)

Items 201–300 of 727

  1. Oncogenic ADAM28 induces gemcitabine resistance and predicts a poor prognosis in pancreatic cancer
    Wei Li, Jing‐Yun Wen, Jie Chen, Xiaokun Ma, Dong‐Hao Wu, Zhan‐Hong Chen, Jianglong Huang · 2019 · World Journal of Gastroenterology
  2. PDAC-ANN: an artificial neural network to predict pancreatic ductal adenocarcinoma based on gene expression
    Almeida, Palloma Porto, Cardoso, Cristina Padre, de Freitas, Leandro Martins · 2020 · BMC Cancer
  3. A FAM83A Positive Feed-back Loop Drives Survival and Tumorigenicity of Pancreatic Ductal Adenocarcinomas
    Neetha Parameswaran, Courtney A. Bartel, Wilnelly M. Hernandez-Sanchez, Kristy L. S. Miskimen, Jacob M. Smigiel, Ahmad Mohammad Khalil, Mark W. Jackson · 2019 · Scientific Reports
  4. Molecular mechanism of the TP53-MDM2-AR-AKT signalling network regulation by USP12
    Urszula Lucja McClurg, Nay C. T. H. Chit, Mahsa Azizyan, Joanne Edwards, Arash Nabbi, Karl T. Riabowol, Sirintra Nakjang, Stuart R. McCracken, Craig N. Robson · 2018 · Oncogene
  5. Early Life Stress and High FKBP5 Interact to Increase Anxiety-Like Symptoms through Altered AKT Signaling in the Dorsal Hippocampus
    Marangelie Criado‐Marrero, Niat T. Gebru, Lauren A. Gould, Taylor M. Smith, Sojeong Kim, Roy J. Blackburn, Chad A. Dickey, Laura J. Blair · 2019 · International Journal of Molecular Sciences
  6. Gene expression profiling of upregulated mRNAs in granulosa cells of bovine ovulatory follicles following stimulation with hCG
    Jacques G. Lussier, Mame Nahé Diouf, Valérie Lévesque, Jean Sirois, Kalidou Ndiaye · 2017 · Reproductive Biology and Endocrinology
  7. PRMT5 promotes cancer cell migration and invasion through the E2F pathway
    Wojciech Barczak, Li Jin, Simon Mark Carr, Shonagh Munro, Samuel Ward, Alexander A Kanapin, Anastasia A. Samsonova, Nicholas Barrie La Thangue · 2020 · Cell Death and Disease
  8. CHD7 Expression Predicts Survival Outcomes in Patients with Resected Pancreatic Cancer
    Lauren Elizabeth Colbert, Aleksandra V. Petrova, Sarah B. Fisher, Brooke G. Pantazides, Matthew Z. Madden, Claire W. Hardy, Matthew D. Warren, Yunfeng Pan, Ganji Purnachandra Nagaraju, Elaine A. Liu et al. · 2014 · Cancer Research
  9. Transcriptional dissection of pancreatic tumors engrafted in mice
    Raquel Martinez-Garcia, David Juan, Antonio Rausell, Manuel Muñoz, Natalia Baños, Camino Menéndez, Pedro Pablo Lopez-Casas, Daniel Rico, Alfonso Valencia, Manuel M. Hidalgo · 2014 · Genome Medicine
  10. A global insight into a cancer transcriptional space using pancreatic data: importance, findings and flaws
    Emanuela Gadaleta, Rosalind J. Cutts, Gavin P. Kelly, Tatjana Crnogorac‐Jurcevic, Hemant Mahendrakumar Kocher, Nicholas Robert Lemoine, Claude Chelala · 2011 · Nucleic Acids Research
  11. Assessment of the stromal contribution to Sonic Hedgehog‐dependent pancreatic adenocarcinoma
    Helene Damhofer, Jan Paul Medema, Veronique L. Veenstra, Liviu Badea, Irinel Popescu, Henk Roelink, Maarten F. Bijlsma · 2013 · Molecular Oncology
  12. Cadherin-11 Is a Cell Surface Marker Up-Regulated in Activated Pancreatic Stellate Cells and Is Involved in Pancreatic Cancer Cell Migration
    Chiara Birtolo, Hung Pham, Susan Morvaridi, Chintan Chheda, Vay Liang W. Go, Andrzej Ptasznik, Mouad Edderkaoui, Michael H. Weisman, Erika H. Noss, Michael B. Brenner et al. · 2016 · American Journal Of Pathology
  13. The Effect of GPRC5a on the Proliferation, Migration Ability, Chemotherapy Resistance, and Phosphorylation of GSK-3β in Pancreatic Cancer
    Bin Liu, Hai Yang, Christian P. Pilarsky, Georg F. Weber · 2018 · International Journal of Molecular Sciences
  14. Pharmacological AMPK activation induces transcriptional responses congruent to exercise in skeletal and cardiac muscle, adipose tissues and liver
    Eric S. Muise, Hong-Ping Guan, Jinqi Liu, Andrea R. Nawrocki, Xiaodong Yang, Chuanlin Wang, Carlos G. Rodríguez, Dan Zhou, Judith N. Gorski, Marc M. Kurtz et al. · 2019 · PLoS ONE
  15. The Steroid Receptor Coactivator-3 Is Required for the Development of Castration-Resistant Prostate Cancer
    Jean C-Y. Tien, Zhaoliang Liu, Lan Liao, Fen Wang, Yixiang Xu, Yelin Wu, Niya Zhou, Michael Ittmann, Jianming Xu · 2013 · Cancer Research
  16. Stromal SPOCK 1 supports invasive pancreatic cancer growth
    Veronique L. Veenstra, Helene Damhofer, Cynthia Waasdorp, Anne Steins, Hemant Mahendrakumar Kocher, Jan Paul Medema, Hanneke W.M. van Laarhoven, Maarten F. Bijlsma · 2017 · Molecular Oncology
  17. Primordial germ cells as a potential shared cell of origin for mucinous cystic neoplasms of the pancreas and mucinous ovarian tumors
    Kevin Meyer Elias, Petros K. Tsantoulis, Jean‐Christophe Tille, Allison F. Vitonis, Leona A. Doyle, Jason L. Hornick, Gürkan Kaya, Laurent Barnes, Daniel William Cramer, Giacomo Puppa et al. · 2018 · The Journal of Pathology
  18. FKBP5 regulates trophoblast-macrophage crosstalk in recurrent spontaneous abortion through PI3K/AKT and NF-κB signaling pathways
    Xin Chen, Qianlin Song, Jia Yu Wang, Rui Ji, Ming Liang Cao, Duan Ying Guo, Yan Zhang, Jing Yang · 2023 · Free Radical Biology and Medicine
  19. Akt2 Regulates Metastatic Potential in Neuroblastoma
    Jingbo Qiao, Sora Lee, Pritha Paul, Lan Qiao, Chase J. Taylor, Cameron E. Schlegel, Nadja C. Colon, Dai H. Chung · 2013 · PLoS ONE
  20. Identification of hub genes with diagnostic values in pancreatic cancer by bioinformatics analyses and supervised learning methods
    Chunyang Li, Xiaoxi Zeng, Haopeng Yu, Yonghong Gu, Wei Zhang · 2018 · World Journal of Surgical Oncology
  21. An ethnobotanical study of wetland flora of Head Maralla Punjab Pakistan
    Muhammad Sajjad Iqbal, Khawaja Shafique Ahmad, Muhammad Azhar Ali, Muhammad Akbar, Ansar Mehmood, Fahim Nawaz, Syed Atiq Hussain, Noshia Arshad, Saba Munir, Hamna Arshad et al. · 2021 · PLoS ONE · Retracted
  22. Bending Tau into Shape: The Emerging Role of Peptidyl-Prolyl Isomerases in Tauopathies
    John Koren, Umesh K. Jinwal, Zachary S. Davey, Janine Kiray, Karthik Arulselvam, Chad A. Dickey · 2011 · Molecular Neurobiology
  23. A Comparative Analysis of Gene-Expression Data of Multiple Cancer Types
    Kun Xu, Juan Cui, Victor N. Olman, Qing Yang, David Puett, Ying Xu · 2010 · PLoS ONE
  24. Analysis of the glyco-code in pancreatic ductal adenocarcinoma identifies glycan-mediated immune regulatory circuits
    Ernesto Rodríguez, Kelly Boelaars, Kari Brown, Katarina Madunić, Thomas van Ee, Frederike Dijk, Joanne Verheij, R. J. Eveline Li, Sjoerd T. T. Schetters, Laura L. Meijer et al. · 2022 · Communications Biology
  25. RETRACTED: Hsp90‐binding immunophilin FKBP51 forms complexes with hTERT enhancing telomerase activity
    Mariana Lagadari, Nadia R. Zgajnar, Luciana I. Gallo, Mario D. Galigniana · 2016 · Molecular Oncology · Retracted
  26. Upregulation of pyruvate kinase M2 expression by fatty acid synthase contributes to gemcitabine resistance in pancreatic cancer
    Shenghua Tian, Pingping Li, Shi Sheng, Xin Jin · 2017 · Oncology Letters
  27. The long coding RNA AFAP1-AS1 promotes tumor cell growth and invasion in pancreatic cancer through upregulating the IGF1R oncogene via sequestration of miR-133a
    Bo Chen, Qinhua Li, Yongping Zhou, Xujing Wang, Qiqi Zhang, Yongkun Wang, Huiren Zhuang, Xiaohua Jiang, Wujun Xiong · 2018 · Cell Cycle
  28. NOXA expression drives synthetic lethality to RUNX1 inhibition in pancreatic cancer
    Josefina Doffo, Stefanos A. Bamopoulos, Hazal Köse, Felix Orben, Chuanbing Zang, Miriam Pons, Alexander T. den Dekker, Rutger W. W. Brouwer, Apoorva Baluapuri, Stefan Habringer et al. · 2022 · Proceedings of the National Academy of Sciences
  29. Blocking Hedgehog release from pancreatic cancer cells increases paracrine signaling potency
    Helene Damhofer, Veronique L. Veenstra, Johanna A.M.G. Tol, Hanneke W.M. van Laarhoven, Jan Paul Medema, Maarten F. Bijlsma · 2014 · Journal of Cell Science
  30. Transcriptomic profiling of taxol-resistant ovarian cancer cells identifies FKBP5 and the androgen receptor as critical markers of chemotherapeutic response
    Nian‐Kang Sun, Shang‐Lang Huang, Pu‐Yuan Chang, Hsing‐Pang Lu, Chuck C.‐K. Chao · 2014 · Oncotarget
  31. Addiction of pancreatic cancer cells to zinc-finger transcription factor ZIC2
    Shingo Inaguma, Hideaki Ito, Miho Riku, Hiroshi Ikeda, Kenji Kasai · 2015 · Oncotarget
  32. Genetic variations associated with gemcitabine treatment outcome in pancreatic cancer
    Liang Li, Jianwei Zhang, Gregory D. Jenkins, Fang Xi Xie, Erin E. Carlson, Brooke L. Fridley, William R. Bamlet, Gloria M. Petersen, Robert R. McWilliams, Liewei Wang · 2016 · Pharmacogenetics and Genomics
  33. Development and validation of a metastasis-related Gene Signature for predicting the Overall Survival in patients with Pancreatic Ductal Adenocarcinoma
    Mengwei Wu, Xiaobin Li, Rui Liu, Hongwei Yuan, Wei Liu, Ziwen Liu · 2020 · Journal of Cancer
  34. mTORC2 promotes cell survival through c-Myc–dependent up-regulation of E2F1
    Zhipeng Zou, Juan Chen, Anling Liu, Xuan Zhou, Qiancheng Song, Chunhong Jia, Zhenguo Chen, Jun Lin, Cuilan Yang, Ming Li et al. · 2015 · The Journal of Cell Biology
  35. The emerging role of FK506-binding proteins as cancer biomarkers: a focus on FKBPL
    Hayley D. McKeen, Donal J. Brennan, Shauna M. Hegarty, Fiona T. Lanigan, Karin Jirström, Christopher Byrne, Anita Yakkundi, Helen O. McCarthy, William M. Gallagher, Tracy Robson · 2011 · Biochemical Society Transactions
  36. The Emerging Role of Large Immunophilin FK506 Binding Protein 51 in Cancer
    Simona Romano, Antonio Sorrentino, Anna Laura Di Pace, Giovanna Nappo, Christopher J. Mercogliano, Maria Fiammetta Romano · 2011 · Current Medicinal Chemistry
  37. FANCI is a negative regulator of Akt activation
    Xiaoshan Zhang, Xiaoyan Lu, Shamima Akhter, Maria-Magdalena Georgescu, Randy J. Legerski · 2016 · Cell Cycle
  38. Integrated whole genome microarray analysis and immunohistochemical assay identifies COL11A1, GJB2 and CTRL as predictive biomarkers for pancreatic cancer
    Defeng Sun, Haoyi Jin, Jun Zhang, Xiaodong Tan · 2018 · Cancer Cell International
  39. Magnesium transporter protein solute carrier family 41 member 1 suppresses human pancreatic ductal adenocarcinoma through magnesium-dependent Akt/mTOR inhibition and bax-associated mitochondrial apoptosis
    Jing Xie, Chien‐shan Cheng, Xiao Yan Zhu, Ye Shen, Li Bin Song, Hao Chen, Zhen Chen, Lu-Ming Liu, Zhi Qiang Meng · 2019 · Aging
  40. LINC01348 suppresses hepatocellular carcinoma metastasis through inhibition of SF3B3-mediated EZH2 pre-mRNA splicing
    Yang-Hsiang Lin, Meng‐Han Wu, Yi‐Chung Liu, Pingchiang C. Lyu, Chau‐Ting Yeh, Kwang‐Huei Lin · 2021 · Oncogene
  41. Interferon alpha-inducible protein 27 (IFI27) is a prognostic marker for pancreatic cancer based on comprehensive bioinformatics analysis
    Shu Huang, Jinglin Zhao, Jianxin Song, Yanqiong Li, Rongxia Zuo, Yalian Sa, Zhihui Ma, Hongmei Ouyang · 2021 · Bioengineered
  42. TRIM29 facilitates gemcitabine resistance via MEK/ERK pathway and is modulated by circRPS29/miR-770–5p axis in PDAC
    Wenjie Huang, Xiaojun Hu, Xiang He, Dongyue Pan, Zhaorong Huang, Zhanfeng Gu, Guobing Huang, Ping Wang, Chunhui Cui, Yingfang Fan · 2024 · Drug Resistance Updates
  43. The therapeutic and diagnostic potential of FKBPL; a novel anticancer protein
    Tracy Robson, Iain F. James · 2012 · Drug Discovery Today
  44. Altered expression of micro-RNA 199a and increased levels of cardiac SIRT1 protein are associated with the occurrence of atrial fibrillation after coronary artery bypass graft surgery
    Aylin Hatice Yamaç, Sıtkı Kucukbuzcu, Mehmet Ozansoy, Özlem Gök, Kürşat Öz, Mehmet Ertürk, Emre Yılmaz, Burak Ersoy, Rahmi Zeybek, Ömer Göktekin et al. · 2016 · Cardiovascular Pathology
  45. Toward improving androgen receptor-targeted therapies in male-dominant hepatocellular carcinoma
    Hong Zhang, Kristen Renee Spencer, Stephen Kevin Burley, Xi Zheng · 2021 · Drug Discovery Today
  46. The interleukin-1 axis and the tumor immune microenvironment in pancreatic ductal adenocarcinoma
    Kelly M. Herremans, Dominique D. Szymkiewicz, Andrea N. Riner, Riley P. Bohan, Gerik W. Tushoski-Alemán, Aaron M. Davidson, Xiang‐Yang Lou, Man Chong Leong, Bayli DiVita Dean, Michael H. Gerber et al. · 2022 · Neoplasia
  47. Functions of the Hsp90-Binding FKBP Immunophilins
    Naihsuan C. Guy, Yenni A. Garcia, Jeffrey C. Sivils, Mario D. Galigniana, Marc B. Cox · 2014 · Sub-cellular biochemistry/Subcellular biochemistry
  48. MAP17 and the double-edged sword of ROS
    Amancio Carnero · 2012 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  49. Regulation patterns in signaling networks of cancer
    Gunnar Schramm, Kannabiran Nandakumar, Rainer König · 2010 · BMC Systems Biology
  50. Combination of a selective activator of the glucocorticoid receptor Compound A with a proteasome inhibitor as a novel strategy for chemotherapy of hematologic malignancies
    Ekaterina A. Lesovaya, Alexander Yu. Yemelyanov, Кирсанов Кирилл Игоревич, А. В. Попа, Gennady A. Belitsky, Якубовская Марианна Геннадиевна, Leo I. Gordon, Steven T. Rosen, Irina V. Budunova · 2012 · Cell Cycle
  51. Downregulation of RPL15 may predict poor survival and associate with tumor progression in pancreatic ductal adenocarcinoma
    Tingting Yan, Xueliang Fu, Jiao Li, Yingnan Bian, Dejun Liu, Rong Hua, Linlin Ren, Chengtao Li, Yongwei Sun, Haoyan Chen et al. · 2015 · Oncotarget
  52. The tRNA pseudouridine synthase TruB1 regulates the maturation of let‐7 miRNA
    Ryota Kurimoto, Tomoki Chiba, Yoshiaki Ito, Takahide Matsushima, Yuki Yano, Kohei Miyata, Yuka Yashiro, Tsutomu Suzuki, Kozo Tomita, Hiroshi Asahara · 2020 · The EMBO Journal
  53. PHLPP1 splice variants differentially regulate AKT and PKCα signaling in hippocampal neurons: characterization of PHLPP proteins in the adult hippocampus
    Travis C. Jackson, Jonathan D. Verrier, Susan L. Semple‐Rowland, Ashok Kumar, Thomas C. Foster · 2010 · Journal of Neurochemistry
  54. Steroid Receptor-Associated Immunophilins: A Gateway to Steroid Signalling.
    Thomas Ratajczak, Carmel Cluning, Bryan K. Ward · 2015 · Europe PMC (PubMed Central)
  55. Comprehensive Analysis of GLUT1 Immune Infiltrates and ceRNA Network in Human Esophageal Carcinoma
    Xu‐Sheng Liu, Yan Ping Gao, Libing Wu, Hua‐Bing Wan, Yan Peng, Jin Yang, Shibo Guo, Yalan Wang, Xueqin Chen, Lu-Meng Zhou et al. · 2021 · Frontiers in Oncology
  56. Integrating network pharmacology to investigate the mechanism of quercetin's action through AKT inhibition in co-expressed genes associated with polycystic ovary syndrome and endometrial cancer
    Mengyuan Li, Yewei Cui, Xue‐Ru Wu, Xunmei Yang, Chenglong Huang, Lili Yu, Ping Yi, Cheng Chen · 2025 · International Journal of Biological Macromolecules
  57. Role of Phosphatidylinositol-3-Kinase Pathway in Head and Neck Squamous Cell Carcinoma
    Li Du, Jingping Shen, Andrew D. Weems, Shi‐Long Lu · 2012 · Journal of Oncology
  58. PHLPP: a putative cellular target during insulin resistance and type 2 diabetes
    Alpana Mathur, Vivek Kumar Pandey, Poonam Kakkar · 2017 · Journal of Endocrinology
  59. Endothelial Scaffolding Protein ENH (Enigma Homolog Protein) Promotes PHLPP2 (Pleckstrin Homology Domain and Leucine-Rich Repeat Protein Phosphatase 2)-Mediated Dephosphorylation of AKT1 and eNOS (Endothelial NO Synthase) Promoting Vascular Remodeling
    Jiaqi Huang, Changhong Cai, Tianyu Zheng, Xinyan Wu, Dongfei Wang, Kaijie Zhang, Bocheng Xu, Ruochen Yan, Hui Gong, Jie Zhang et al. · 2020 · Arteriosclerosis Thrombosis and Vascular Biology
  60. FKBP5 Regulates RIG-I-Mediated NF-κB Activation and Influenza A Virus Infection
    Wenzhuo Hao, Lingyan Wang, Shitao Li · 2020 · Viruses
  61. Systematic analysis of gene expression alterations and clinical outcomes of adenylate cyclase-associated protein in cancer
    Shuanshuan Xie, Changxing Shen, Min Tan, Ming Li, Xiaolian Song, Changhui Wang · 2017 · Oncotarget
  62. LKB1 obliterates Snail stability and inhibits pancreatic cancer metastasis in response to metformin treatment
    Lele Song, Jingyu Guo, Renxu Chang, Xiaobo Peng, Jie Li, Xiaorong Xu, Xianbao Zhan, Lixing Zhan · 2018 · Cancer Science
  63. PAICS, a De Novo Purine Biosynthetic Enzyme, Is Overexpressed in Pancreatic Cancer and Is Involved in Its Progression
    Sumit Agarwal, Balabhadrapatruni V. S. K. Chakravarthi, Hyung‐Gyoon Kim, Nirzari Gupta, Kevin Hale, Sai Akshaya Hodigere Balasubramanya, Patsy G. Oliver, Dafydd G. Thomas, Isam‐Eldin A. Eltoum, Donald J. Buchsbaum et al. · 2020 · Translational Oncology
  64. PHLPPing the Script: Emerging Roles of PHLPP Phosphatases in Cell Signaling
    Timothy R. Baffi, Ksenya Cohen‐Katsenelson, Alexandra C. Newton · 2020 · The Annual Review of Pharmacology and Toxicology
  65. Decreased LKB1 predicts poor prognosis in Pancreatic Ductal Adenocarcinoma
    Jian‐Yu Yang, Shu-Heng Jiang, Dejun Liu, Xiaomei Yang, Yan‐Miao Huo, Jiao Li, Rong Hua, Zhigang Zhang, Yongwei Sun · 2015 · Scientific Reports
  66. A role for synapsin in FKBP51 modulation of stress responsiveness: Convergent evidence from animal and human studies
    Ulrike Schmidt, Dominik R. Buell, Irina A. Ionescu, Nils C. Gassen, Florian Holsboer, Marc B. Cox, Božidar Novak, Christine W. Huber, Jakob Hartmann, Mathias V. Schmidt et al. · 2014 · Psychoneuroendocrinology
  67. High hypoxia status in pancreatic cancer is associated with multiple hallmarks of an immunosuppressive tumor microenvironment
    Hassan Sadozai, Animesh Acharjee, Hateem Zafar Kayani, Thomas Gruber, Reginald M. Gorczynski, Bernard Burke · 2024 · Frontiers in Immunology
  68. Screening and identification of hub genes in pancreatic cancer by integrated bioinformatics analysis
    Qing Chen, Dongmei Yu, Yingying Zhao, Jiajun Qiu, Yufeng Xie, Min Tao · 2019 · Journal of Cellular Biochemistry
  69. Upregulation of CENPM facilitates tumor metastasis via the mTOR/p70S6K signaling pathway in pancreatic cancer
    Chenlei Zheng, Tan Zhang, Ding Li, Chongchu Huang, Hengjie Tang, Xiaofeng Ni, Bicheng Chen · 2020 · Oncology Reports
  70. An Integrated Data Analysis of mRNA, miRNA and Signaling Pathways in Pancreatic Cancer
    Ehsan Sohrabi, Ehsan Rezaie, Mohammad Heiat, Yousef Sefidi Heris · 2021 · Biochemical Genetics
  71. Numb regulates acinar cell dedifferentiation and survival during pancreatic damage and acinar to ductal metaplasia
    Renee L. Greer, B. K. Staley, Angela Liou, M. Hebrok · 2013 · Gastroenterology
  72. Molecular Pathways: PI3K Pathway Phosphatases as Biomarkers for Cancer Prognosis and Therapy
    Muhan Chen, Dawid Grzegorz Nowak, Lloyd C. Trotman · 2014 · Clinical Cancer Research
  73. Activated growth signaling pathway expression in Ewing sarcoma and clinical outcome
    Jaume Mora, Eva Rodríguez, Carmen de Torres, Teresa M. Cardesa‐Salzmann, José Ríos, Teresa Hernández, Antonio Cardesa, Enrique de Álava · 2011 · Pediatric Blood & Cancer
  74. A FKBP5 mutation is associated with Paget’s disease of bone and enhances osteoclastogenesis
    Bingru Lu, Yulian Jiao, Yinchang Wang, Jing Dong, Muyun Wei, Bin Cui, Yafang Sun, Laicheng Wang, Bingchang Zhang, Zi‐Jiang Chen et al. · 2017 · Experimental & Molecular Medicine
  75. Overexpression of MIST1 reverses the epithelial-mesenchymal transition and reduces the tumorigenicity of pancreatic cancer cells via the Snail/E-cadherin pathway
    Xiaogang Li, Hengyu Chen, Zhiqiang Liu, Ye Zeng, Shanmiao Gou, Chunyou Wang · 2018 · Cancer Letters
  76. Identification of hub genes and analysis of prognostic values in pancreatic ductal adenocarcinoma by integrated bioinformatics methods
    Yi Lü, Chujun Li, Honglei Chen, Weijie Zhong · 2018 · Molecular Biology Reports
  77. Analysis of gene expression and methylation datasets identified ADAMTS9, FKBP5, and PFKBF3 as biomarkers for osteoarthritis
    Zhaofang Li, Rongqiang Zhang, Xiaoli Yang, Dandan Zhang, BaoRong Li, Di Zhang, Qiang Li, Yongmin Xiong · 2018 · Journal of Cellular Physiology
  78. MCM2 and NUSAP1 Are Potential Biomarkers for the Diagnosis and Prognosis of Pancreatic Cancer
    Yajun Deng, Hanyun Ma, Jinyong Hao, Qiqi Xie, Ruochen Zhao · 2020 · BioMed Research International
  79. Potential Prognostic Biomarkers of OSBPL Family Genes in Patients with Pancreatic Ductal Adenocarcinoma
    Cheng‐Wei Chou, Yu-Hsiu Hsieh, Su‐Chi Ku, Wan‐Jou Shen, Gangga Anuraga, Hoang Dang Khoa Ta, Kuen‐Haur Lee, Yu‐Cheng Lee, Cheng‐Hsien Lin, Chih‐Yang Wang et al. · 2021 · Biomedicines
  80. A Molecular Link between AKT Regulation and Chemotherapeutic Response
    Christian C. Dibble, Brendan D. Manning · 2009 · Cancer Cell
  81. Towards the clinical implementation of pharmacogenetics in bipolar disorder
    Naji C. Salloum, Michael J. McCarthy, Susan G. Leckband, John R. Kelsoe · 2014 · BMC Medicine
  82. MACC1 regulates Fas mediated apoptosis through STAT1/3 – Mcl-1 signaling in solid cancers
    Harikrishnan Radhakrishnan, Katharina Ilm, Wolfgang Walther, Senji Shirasawa, Takehiko Sasazuki, Peter T. Daniel, Bernhard F. Gillissen, Ulrike Stein · 2017 · Cancer Letters
  83. Clinical implication of Sox9 and activated Akt expression in pancreatic ductal adenocarcinoma
    Suhua Xia, Zhenyu Feng, Xiaowei Qi, Yuan Yin, Jianqiang Jin, Yufeng Wu, Hao-Rong Wu, Yizhong Feng, Min Tao · 2014 · Medical Oncology
  84. Pathway-Based Analysis of Genome-Wide Association Data Identified SNPs in HMMR as Biomarker for Chemotherapy- Induced Neutropenia in Breast Cancer Patients
    Behzad Bidadi, Duan Liu, Krishna R. Kalari, Matthias Rübner, Alexander Hein, Matthias W. Beckmann, Brigitte Kathrin Rack, Wolfgang Janni, Peter Andreas Fasching, Richard M. Weinshilboum et al. · 2018 · Frontiers in Pharmacology
  85. Functional role of BTB and CNC Homology 1 gene in pancreatic cancer and its association with survival in patients treated with gemcitabine
    Xudong Huang, Jian Zheng, Jun Li, Xu Che, Wenle Tan, Wen Tan, Mingming Shao, Xinxin Cheng, Zhongli Du, Yanjie Zhao et al. · 2018 · Theranostics
  86. Potential functional variants in SMC2 and TP53 in the AURORA pathway genes and risk of pancreatic cancer
    Yun Feng, Hongliang Liu, Bensong Duan, Zhensheng Liu, James L. Abbruzzese, Kyle M. Walsh, Xuefeng Zhang, Qingyi Wei · 2019 · Carcinogenesis
  87. Development of a four-gene prognostic model for pancreatic cancer based on transcriptome dysregulation
    Jie Yan, Liangcai Wu, Congwei Jia, Shuangni Yu, Zhaohui Lu, Yueping Sun, Jie Chen · 2020 · Aging
  88. Circulating cancer‐associated extracellular vesicles as early detection and recurrence biomarkers for pancreatic cancer
    Yusuke Yoshioka, Manami Shimomura, Keigo Saito, Hideshi Ishii, Yuichiro� Doki, Hidetoshi Eguchi, Tetsuya Nakatsura, Takao Itoi, Masahiko Kuroda, Masaki Mori et al. · 2022 · Cancer Science
  89. IFNs, ISGylation and cancer: Cui prodest?
    Andrea Sgorbissa, Claudio Brancolini · 2012 · Cytokine & Growth Factor Reviews
  90. Unraveling the Role of Peptidyl-Prolyl Isomerases in Neurodegeneration
    Melanie Gérard, Angélique Deleersnijder, Jonas Demeulemeester, Zeger Debyser, Veerle Baekelandt · 2011 · Molecular Neurobiology
  91. Comprehensive analysis of expression profile and prognostic significance of interferon regulatory factors in pancreatic cancer
    Ke Zhang, Panling Xu, Yujie Li, Shu Dong, Huifeng Gao, Lianyu Chen, Hao Chen, Zhen Chen · 2022 · BMC Genomic Data
  92. Discovery of genetic biomarkers contributing to variation in drug response of cytidine analogues using human lymphoblastoid cell lines
    Liang Li, Brooke L. Fridley, Krishna R. Kalari, Nifang Niu, Gregory D. Jenkins, Anthony J. Batzler, Ryan Abo, Daniel J. Schaid, Liewei Wang · 2014 · BMC Genomics
  93. Assembly of the FKBP51–PHLPP2–AKT signaling complex in cerebral ischemia/reperfusion injury in rats
    Xiue Wei, Feng-Yu Zhang, Kai Wang, Qingxiu C. Zhang, Liangqun Rong · 2014 · Brain Research
  94. Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer
    William Adrian Hall, Aleksandra V. Petrova, Lauren Elizabeth Colbert, Claire W. Hardy, Sarah B. Fisher, Burcu Saka, Joseph W. Shelton, Matthew D. Warren, Brooke G. Pantazides, K. Gandhi et al. · 2013 · Oncogene
  95. Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer
    Giuseppina Sannino, Nicole S. Armbruster, Mona Bodenhöfer, Ursula Haerle, Diana Behrens, Malte Buchholz, Ulrich Rothbauer, Bence Sipos, Christian Schmees · 2016 · Oncotarget
  96. Overexpressed gene signature of EPH receptor A/B family in cancer patients-comprehensive analyses from the public high-throughput database.
    Nam Nhut Phan, Shirui Liu, Chih‐Yang Wang, Hui‐Ping Hsu, Ming‐Derg Lai, Chung-Yen Li, Chien‐Fu Chen, Chung-Chieh Chiao, Meng‐Chi Yen, Zhengda Sun et al. · 2020 · PubMed Central
  97. Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma
    Jiacheng Huang, Zhitao Chen, Chenchen Ding, Shengzhang Lin, Dalong Wan, Kuiwu Ren · 2021 · Frontiers in Oncology
  98. FKBP38-Bcl-2 interaction: a novel link to chemoresistance
    Bo‐Hwa Choi, Ho Sup Yoon · 2011 · Current Opinion in Pharmacology
  99. Calmodulin-like protein 3 is an estrogen receptor alpha coregulator for gene expression and drug response in a SNP, estrogen, and SERM-dependent fashion
    Sisi Qin, James N. Ingle, Mohan Liu, Jia Yu, Donald Lawrence Wickerham, Michiaki Kubo, Richard M. Weinshilboum, Liewei Wang · 2017 · Breast Cancer Research
  100. Reverse-Phase Protein Array Analysis to Identify Biomarker Proteins in Human Pancreatic Cancer
    Yu-Jing Huang, Marsha L. Frazier, Nianxiang Zhang, Qian Liu, Chongjuan Wei · 2013 · Digestive Diseases and Sciences